← All Sponsors
SPONSOR

Xiamen Amoytop Biotech Co., Ltd.

Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3
Conditions studied: Essential ThrombocythemiaIdiopathic Short Stature
NCT06552429 Phase 2
Recruiting

Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET

Essential Thrombocythemia
China View Trial →
NCT06927310 Phase 3
Recruiting

The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature

Idiopathic Short Stature
China View Trial →